- Home
- CYCC vs DTIL Comparison
CYCC vs DTIL Comparison
Compare CYCC & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCC
- DTIL
- Stock Information
- Founded
- CYCC 1992
- DTIL 2006
- Country
- CYCC Malaysia
- DTIL United States
- Employees
- CYCC N/A
- DTIL N/A
- Industry
- CYCC Biotechnology: Pharmaceutical Preparations
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- CYCC Health Care
- DTIL Health Care
- Exchange
- CYCC Nasdaq
- DTIL Nasdaq
- Market Cap
- CYCC 47.6M
- DTIL 56.2M
- IPO Year
- CYCC N/A
- DTIL 2019
- Fundamental
- Price
- CYCC $0.35
- DTIL $5.10
- Analyst Decision
- CYCC Strong Buy
- DTIL Strong Buy
- Analyst Count
- CYCC 1
- DTIL 3
- Target Price
- CYCC $11.00
- DTIL $37.67
- AVG Volume (30 Days)
- CYCC 7.1M
- DTIL 199.8K
- Earning Date
- CYCC 05-13-2025
- DTIL 05-16-2025
- Dividend Yield
- CYCC 43.71%
- DTIL N/A
- EPS Growth
- CYCC N/A
- DTIL N/A
- EPS
- CYCC N/A
- DTIL 1.04
- Revenue
- CYCC $43,000.00
- DTIL $68,696,000.00
- Revenue This Year
- CYCC $137.21
- DTIL N/A
- Revenue Next Year
- CYCC N/A
- DTIL $30.20
- P/E Ratio
- CYCC N/A
- DTIL $5.39
- Revenue Growth
- CYCC N/A
- DTIL 40.98
- 52 Week Low
- CYCC $0.17
- DTIL $3.61
- 52 Week High
- CYCC $4.00
- DTIL $13.44
- Technical
- Relative Strength Index (RSI)
- CYCC 65.97
- DTIL 48.33
- Support Level
- CYCC $0.23
- DTIL $5.02
- Resistance Level
- CYCC $0.30
- DTIL $5.97
- Average True Range (ATR)
- CYCC 0.06
- DTIL 0.38
- MACD
- CYCC 0.01
- DTIL 0.02
- Stochastic Oscillator
- CYCC 68.57
- DTIL 18.69
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib and plogosertib.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.